Edited by Dr Alaa AbouElfetouh (Alexandria University, Egypt)
We are proud to announce the call for papers for Combatting antimicrobial resistance in Africa through surveillance and capacity building. This will be a collection of original works and reviews focussing on research, from Africans and non-Africans alike, targeting antimicrobial resistance challenges facing the African continent in both community and hospital settings.
Edited by Sarah Tschudin-Sutter
We are proud to announce the publication of Impact of the environment on healthcare-associated infections . This is a collection of original works and reviews focusing on the role of the environment in promoting healthcare-associated infections and specific interventions targeting the hospital environment.
Health Policy and the Management of Antimicrobial Resistance in LMICs is now open for submissions.
This is a cross-journal series to highlight the challenges and developments within antimicrobial drug policies in low and middle income countries. Both reviews and original research articles are welcome.
In their recent paper, Seven Aghdassi and colleagues demonstrate that known contact to SARS-CoV-2 cases and association to outbreaks at the ward level are primary risk factors for nosocomial SARS-CoV-2 infections. Therefore, it is essential to quickly identify these patients and implement preemptive isolation methods. Thus enabling routine patient care to continue during the pandemic.
10 June 2022
13 May 2022
Here, we compile some handy tips for the community, from early-career researchers to clinicians on peer review. It may seem like a basic part of a reseacher’s role, but many basic and clinical researchers don’t get much training in the cornerstone of this life cycle of modern scientific literature.
Assessment by expert peers improves the quality of manuscripts and provides a level of control in scientific communication.
We've put together a short guide (Read more).
10 June 2022
13 May 2022
Antimicrobial Resistance and Infection Control believes that future solutions require a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, interventions to prevent transmission and infection, and insight into the difference between settings with limited, middle or high resources.
We are pleased to highlight that Antimicrobial Resistance & Infection Control recognises that scientifically sound, high quality manuscripts are often turned away from broad-scope "high-impact" journals based on the issue of "general interest." The journal will consider rapid publication of such manuscripts - if they are submitted together with the original peer reviewer reports, letter of rejection, and a rebuttal. Please also mention this in your cover letter.
Please note that additional peer review may be necessary and the final decision will be made by the Editor.
Antimicrobial Resistance and Infection Control is pleased to announce a new article collection entitled Society guidelines for best practices. Our aim is to offer the journal’s associated societies the opportunity to publish their guidelines in order to make them available for a broader audience.
Your browser needs to have JavaScript enabled to view this timeline
Christina Vandenbroucke-Grauls, Editor-in-Chief
Dr Vandenbroucke-Grauls is professor of Medical Microbiology at the VU University (Amsterdam), The Netherlands. She holds an MD from the Catholic University of Leuven (Belgium) and a PhD from the Utrecht University (Utrecht, The Netherlands). She also holds a degree in Epidemiology (PhD equivalent) from the Dutch Society for Epidemiology. She is a Fellow of the Royal College of Physicians (FRCP).
Professor Vandenbroucke-Grauls is head of Department of Medical Microbiology & Infection Control at the VU University Medical Center. For over ten years she served as chair of the Dutch Working Party on Infection Control. She also served in several professional boards and national and international scientific committees. Her main work interest is in infection control and antimicrobial resistant pathogens (MRSA and ESBL- and carbapenemase-producing Enterobacteriaceae in particular).
Speed
24 days to first decision for all manuscripts
70 days to first decision for reviewed manuscripts only
142 days from submission to acceptance
17 days from acceptance to publication
Citation Impact
4.887 - 2-year Impact Factor
5.171 - 5-year Impact Factor
2.019 - Source Normalized Impact per Paper (SNIP)
1.456 - SCImago Journal Rank (SJR)
Usage
1,535,859 downloads (2021)
3,787 Altmetric Mentions